Cardiac Regeneration

The use of stem cell and cell therapy to repair or replace damaged heart tissue is called cardiac regeneration.

There is hope that various tissues or portions of the heart will eventually develop and the ability to regenerate due to the progress in cardiac science and new scientific advances.

Subtopics

Cell Based Heart Repair | Progenitor Cells from the Adult Heart | Human Pluripotent Stem Cell-Derived Cardiomyocytes | Direct Cardiac Reprogramming | Cardiomyocyte Transplantation | Tissue Engineered Heart repair | Imaging Cardiac Stem Cell Therapy | Stem Cell Transplant Immunology | Tissue graft cardiac cell replacement | Cardiac remodeling | Cardiac regenerative therapy | Congenital heart disease and regeneration | Heart repair, heart tissue regeneration and stem cells | Biomimetic heart valve replacement | Stem cell-derived engineered cardiac tissue

Market Statistics:

The global regenerative medicine market was estimated at USD 27.29 billion in 2020, and it is predicted to increase at a CAGR of 11.27% from 2021 to 2027.